Although there are no standard criteria for the clinical and biomarker evidence required to support disease modification, clinical measures such as a change in trajectory of decline, an increasing drug versus placebo difference over time, an increased time to event, and an enduring change after discontinuation support this terminology
Plasma carnitine levels vary with age, typically increasing until approximately 70 years before declining in parallel with reduced muscle mass and metabolic capacity
High blood sugar becomes more likely when odor appears with thirst, frequent urination, blurred vision, weight loss, or unexplained fatigue
Longer treatment duration does not guarantee weight maintenance, but it may improve the chances of sustaining healthy behaviors once medication support is removed
There would be no grandfathering or exemptions for existing patients, she added
Exercise increases IGF-1 and angiogenesis